tiprankstipranks
Trending News
More News >
Pharmadrug (TSE:PHRX)
:PHRX
Canadian Market
Advertisement

Pharmadrug (PHRX) Technical Analysis

Compare
32 Followers

Summary of all the Indicators

Overall Consensus
Strong Sell
1Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Pharmadrug’s (PHRX) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pharmadrug is a Sell.
Pharmadrug’s (PHRX) 20-Day exponential moving average is 0.01, while Pharmadrug’s (PHRX) share price is <C$0.1, making it a Sell.
Pharmadrug’s (PHRX) 50-Day exponential moving average is 0.01, while Pharmadrug’s (PHRX) share price is <C$0.1, making it a Sell.

Pharmadrug (PHRX) Pivot Points

Jul 29, 2025, 01:07 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Fibonacci
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmadrug (PHRX) Moving Averages

Jul 29, 2025, 01:07 AM
Period
Simple
Exponential
MA5
0.01Sell
0.01Sell
MA10
0.01Sell
0.01Sell
MA20
0.01Sell
0.01Sell
MA50
0.01Sell
0.01Sell
MA100
0.01Sell
0.01Sell
MA200
0.02Sell
0.02Sell
Pharmadrug’s (PHRX) 10-Day exponential moving average is 0.01, while Pharmadrug’s (PHRX) share price is <C$0.1, making it a Sell.
Pharmadrug’s (PHRX) 100-Day exponential moving average is 0.01, while Pharmadrug’s (PHRX) share price is <C$0.1, making it a Sell.
Pharmadrug’s (PHRX) stock price is <C$0.1 and Pharmadrug’s (PHRX) 50-day simple moving average is 0.01, creating a Sell signal.
Pharmadrug’s (PHRX) stock price is <C$0.1 and Pharmadrug’s (PHRX) 100-day simple moving average is 0.01, creating a Sell signal.
Pharmadrug’s (PHRX) stock price is <C$0.1 and Pharmadrug’s (PHRX) 200-day simple moving average is 0.02, creating a Sell signal.

Pharmadrug (PHRX) Technical Indicators

Jul 29, 2025, 01:07 AM
Name
Value
Implied Action
RSI (14)
49.34
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
50.00
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
30.86
Neutral
Williams %R
-50.00
Buy
CCI (14)
-11.49
Neutral
ATR (14)
<0.01
-
Ultimate Oscillator
67.69
Neutral
ROC
0.00
Sell
Pharmadrug’s (PHRX) Relative Strength Index (RSI) is 49.34, creating a Neutral signal.
Pharmadrug’s (PHRX) Trend Strength Indicator (ADX) is 30.86, creating a Neutral signal.
Pharmadrug’s (PHRX) Commodity Channel Index (CCI) is -11.49, creating a Neutral signal.

FAQ

Is PHRX a Buy, Hold, or Sell?
Based on PHRX’s technical indicators, PHRX is a Strong Sell.
    What is PHRX’s RSI (14)?
    PHRX’s RSI (14) is 49.34, which suggests PHRX is a Neutral.
      What is PHRX’s MACD?
      PHRX’s MACD is >-0.01, which suggests PHRX is a Sell.
        What is PHRX’s 5-day moving average?
        PHRX’s 5-day moving average is 0.01, which suggests PHRX is a Sell.
          What is PHRX’s 20-day moving average?
          PHRX 20-day moving average is 0.01, which suggests PHRX is a Sell.
            What is PHRX’s 50-day moving average?
            PHRX’s 50-day moving average is 0.01, which suggests PHRX is a Sell.
              What is PHRX’s 200-day moving average?
              PHRX’s 200-day moving average is 0.02, which suggests PHRX is a Sell.
                What is PHRX’s Williams % R (14)?
                PHRX’s Williams % R (14) is -50.00, which suggests PHRX is a Buy.
                  What is PHRX’s CCI (14)?
                  PHRX’s CCI (14) is -11.49, which suggests PHRX is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis